Charles River Endosafe Cartridge Manufacturing Goes Fully Automated at Massachusetts Facility

Charles_River_Laboratories news and statistics

Charles River Laboratories has completed automation of its Endosafe Cartridge Technology manufacturing suite in Wilmington, Massachusetts, reporting double-digit gains in productivity, capacity and product consistency ahead of full operational scale-up in Q3 2026.

WuXi Biologics FDA PLI Approval Secured for MFG8 Facility to Accelerate Commercial Supply of Autoimmune Therapy

Wuxi Biologics News

WuXi Biologics’ MFG8 facility in Hebei has successfully cleared a rigorous seven-day U.S. FDA Pre-License Inspection. This crucial WuXi Biologics FDA PLI Approval paves the way for the scaled commercial supply of a highly anticipated blockbuster autoimmune therapy, reinforcing the company’s unblemished 100% FDA PLI success rate and robust global quality standards.